The effective of case management on reducing the relapse rate in schizophrenic patients, Surat Thani Hospital
Article Sidebar
Main Article Content
Abstract
Background: Patients with relapsed schizophrenia often face challenges in recovery, including functional, cognitive, and emotional impairments. The most common relapse factors are medication nonadherence, treatment discontinuation, and inconsistent care. Therefore, promoting adherence to medication, strengthening family support, and implementing multidisciplinary care tailored to patient needs are crucial may reduce relapse risk.
Method: This study employed a quasi-experimental one-group pretest–posttest design to examine the effects of case management on medication adherence and relapse among schizophrenic patients in the Psychiatric and Drug Addiction Unit at Surat Thani Hospital. The sample consisted of 31 purposively selected patients with relapsed schizophrenia. Research instruments included: (1) a case management program, (2) the Psychotic Symptoms Rating Scale (BPRS; reliability = 0.80) for data collection, and (3) the Medication Adherence Scale (MARS; reliability = 0.71) as the experimental control tool. Data were analyzed using descriptive statistics and the Wilcoxon signed-rank test.
Results: Psychotic symptoms including disorganized thoughts, hallucinations, and abnormal thinking were significantly reduced after case management compared with pre-intervention, indicating decreased relapse. Additionally, medication adherence was significantly higher post-intervention, with a statistically significant difference (p < 0.05).
Conclusion: Case management enhances medication adherence and may reduce relapse risk among patients with schizophrenia. This model can be integrated into psychiatric and mental health services as an effective relapse prevention strategy.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
World Health Organization.The ICD-10 Classification of Mental and Behavioral Disorder:Clinical Descriptions and Diagnotic Guidelines. Switzerland: World Health Organization; 1992.
Robinson, D., Woerner, M. G., Alvir, J. M. J., Bilder, R., Goldman, R., Geisler, S., & al, e. Predictors of Relapse Following Response From a First Episode of Schizophrenia or Schizoaffective Disorder. Archives of General Psychiatry. 1999;53(6):241-247.
Olivares, J. M., Sermon, J., Hemels, M., & Schreiner, A. Definitions and drivers of relapse in patients with schizophrenia: a systematic literature review. Annals General Psychiatry. 2013 ;12(1):32.
Sullivan, G., Well, K.B., Morgenstem,H.,and Leake,B. Identifiable modifiable risk factor for rehospitalization: a case-control study of seriously mentally ill persons in Mississippi. American Journal of Psychiatry. 1995;152:1749-56.
Chen, A. Noncompliance in community :a review of clinical interventions. Hospital and Community Psychiatry. 1991;42:282-287.
Lysaker, P. H., Roe, D., & Yanos, P. T. Toward understanding the insight paradox: Internalized stigma moderates the association between insight and social functioning, hope, and self-esteem among people with schizophrenia spectrum disorders. Schizophrenia Bulletin. 2007; 33(1):192-199.
Al-yahya, N. Effects of Psycho Education Intervention in Improving Insight and Medication Compliance of Schizophrenic Clients, Riyadh, Saudi Arabia. World Journal of Medical Sciences. 2014;11(3):289-300.
Lincoln, T. M., Wilhelm, K., & Nestoriuc, Y. Effectiveness of psychoeducation for relapse, symptoms, knowledge, adherence and functioning in psychotic disorders: a meta-analysis. Schizophrenia Research. 2007;96(1-3):232-245.
Nuechterlein, K. H., Dawson, M. E., Ventura, J., Gitlin, M., Subotnik, K. L., Snyder, K. S., . . . Bartzokis, G. The vulnerability/ stress model of schizophrenia relapse: a longitudinal study. Acta Psychiatrica Scandinavica. 1994;89(382):58-64.
Kavanagh, D. J.. Recent developments in expressed emotion and schizophrenia. The British Journal of Psychiatry. 1992;160(5):601-20.
Kochaporn R. Predicting Factor of psychiatric symtom in Person with Schizophrenia [Master of Nursing Science Thesis]. Bangkok: Chulalongkorn University; 2013.
Umaporn K. Factor predicting medication adherence behacior of schizophrenic patiens in Community[Master of Nursing Science Thesis]. Bangkok: Chulalongkorn University; 2013.
Pitschel-Walz, G., Leucht, S., Bduml, J., Kissling, W., & R., E. The Effect of Family Interventions on Relapse and Rehospitalization in Schizophrenia-A Meta-analysis. Schizophrenia Bulleti. 2001;27(1):73-92.
Zygmunt, A., Olfson, M., Boyer, C. A., & Mechanic, D.Interventions to improve medication adherence in schizophrenia. Am J Psychiatry Journal. 2002;159(10):1653-64.
Chan, S., Mackenzie, A., Ng, D., & Leung, J.An evaluation of the implementation of case management in the community psychiatric nursing service.Journal of Advanced Nursing. 2000;31(1):144-156.
Tongpoon C.Effects of conmmunity Case management on psychotic symtom of Complex schizophrenia patients in Chaturaphark Phiman Distric Roi-et province. Journal of Research and Health Innovation Development. 2024;5(3):137-145.
Wattanaporn P.The Effect of Case Managemeent by Advance Practice Nurse on Relapse in Person with Schozophrenia.The Journal of Nursing and Midwifery Practice. 2018;5(2):5-18.
Nusani A. The Effect of Case management to Overall ability among schizophrenia patient with the risk for violence.Juornal of Somdet Chaopraya Institute of Psychiatry. 2020;14(1) :10-22.
Orathai K et al.Inpatient mental service cost in public hospitals using data from cost per disease project.HISPA Comperdium. 2025;2(4):1-20.
Powell, S. K., & Tahan, H. A. Case management: a practice guide for education and practice: Lippincott Williams & Wilkins; 2010.
Peplau, H. E. Interpersonal relations in nursing: A conceptual framework of reference for psychodynamic nursing. New York: Springer Publishing Co, Inc; 1991.
Brown NW. Psychoeducational groups : process and practice. 2nd ed. New York: Brunner-Routledge; 2004.
Anderson, C. M., Reiss, D. J., & Hogarty, G. E. Schizophrenia and the family a practitioner's guide to psychoeducation and management. New York: A division of guilford publications; 1986.
Lemeshow S, Hosmer DW, Klar J, Lwanga SK. Adequacy of Sample Size in Health Studies. New York :John Wiley & Sons; 1990.
Meijej BV,Kruitwagen C,Gaag MVD, Kahn RS,Grypdonck MHF. An intervention study to prevent relapse in patient with schizophrenia.Journal of Nursing Scholaship. 2006;38(1):42-49.
Overall, J. E., & Gorham, D. R. The Brief Psychiatric Rating Scale (BPRS): Recent developments in ascertainment and scaling. Psychopharmacology Bulletin.1988;24(1):97-99.
Thompson,K.,Kulkarni,J,&Sergejew,AA.Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses.Schizopheniar Research. 2000;42(3):241–247
Pimmada P. The Effects of a Telephone Intervention Program on Medical Adherence Among People with Mental Health Problems.The Journal of Facalty of nursing Burapha university. 2021;29(2):95-104.
Farrelly S, Brown G,Szmukler G,Rose D,Birchwood M,MarshallM,et al Can the therapeutic relationship predict 18 month outcomes for individuals with psychosis. Psychiatry Research. 2014;220(1-2):585-591.
Rathanooch P. The Effect of Therapeutic Relationship Combined with Telephone Continuing Care Program on Medical Adherence in Persons with Schizophrenia. Royal Thai Navy Medical Journal. 2018;45(3):493-508.
Steinacher B, Mausolff L, Gusy B. The effects of a clinical care pathway for schizophrenia: a before and after study in 114 patients. Deutsches Arzteblatt international. 2012;109(46):788-794.
